Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler A Kokjohn

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Biomarker Insights|March 28, 2013
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathologyChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 27, 2009
Patients with Alzheimer disease have altered transmitral flow: echocardiographic analysis of the vortex formation timeMarek Belohlavek, Panupong Jiamsripong, Anna M Calleja, et al.
Molecular Neurodegeneration|October 9, 2010
The biochemical aftermath of anti-amyloid immunotherapyChera L Maarouf, Ian D Daugs, Tyler A Kokjohn, et al.
Neurological Research|December 16, 2005
Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's diseaseDesiree Watson, Eduardo Castaño, Tyler A Kokjohn, et al.
Journal of Neurotrauma|December 28, 2012
Neurochemical profile of dementia pugilisticaTyler A Kokjohn, Chera L Maarouf, Ian D Daugs, et al.
Plos One|April 5, 2013
Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapyAlex E Roher, David H Cribbs, Ronald C Kim, et al.
Plos One|November 17, 2011
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingChera L Maarouf, Ian D Daugs, Tyler A Kokjohn, et al.
Molecular Neurodegeneration|November 22, 2008
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutationsChera L Maarouf, Ian D Daugs, Salvatore Spina, et al.
Plos One|August 29, 2014
Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseChera L Maarouf, Tyler A Kokjohn, Douglas G Walker, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2008
Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's diseaseGregory D Van Vickle, Chera L Esh, Tyler A Kokjohn, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Biomarker Insights|March 28, 2013
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathologyChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 27, 2009
Patients with Alzheimer disease have altered transmitral flow: echocardiographic analysis of the vortex formation timeMarek Belohlavek, Panupong Jiamsripong, Anna M Calleja, et al.
Molecular Neurodegeneration|October 9, 2010
The biochemical aftermath of anti-amyloid immunotherapyChera L Maarouf, Ian D Daugs, Tyler A Kokjohn, et al.
Neurological Research|December 16, 2005
Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's diseaseDesiree Watson, Eduardo Castaño, Tyler A Kokjohn, et al.
Journal of Neurotrauma|December 28, 2012
Neurochemical profile of dementia pugilisticaTyler A Kokjohn, Chera L Maarouf, Ian D Daugs, et al.
Plos One|April 5, 2013
Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapyAlex E Roher, David H Cribbs, Ronald C Kim, et al.
Plos One|November 17, 2011
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingChera L Maarouf, Ian D Daugs, Tyler A Kokjohn, et al.
Molecular Neurodegeneration|November 22, 2008
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutationsChera L Maarouf, Ian D Daugs, Salvatore Spina, et al.
Plos One|August 29, 2014
Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseChera L Maarouf, Tyler A Kokjohn, Douglas G Walker, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2008
Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's diseaseGregory D Van Vickle, Chera L Esh, Tyler A Kokjohn, et al.
Pageof 5